US Drug Recall Register
Class III · Low risk Terminated Initiated Apr 17, 2018 (8 years ago)

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specification: Low dissolution outside of specifications

What was recalled

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

Recalling firm
Rhodes Pharmaceuticals, L.P.
NDC code
42858-402-45
Origin
RI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0710-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methylphenidate recalls

See all